UK Clinical Vaccine Network Conference 2022

Bringing together and showcasing the work of the UK clinical vaccine community, to facilitate co-operation and collaborate on future challenges.

Register now

It is with great excitement that we can announce this year’s Clinical Vaccine Network Conference will be held in person at the Royal College of Physicians, London.

Hosted on the 30th June, this event will cover a wide spectrum of issues in vaccine development, presentations on the latest research, and the future of vaccines.

Whilst this conference will be made available to join virtually we thoroughly recommend attending in person to not miss out on this excellent networking opportunity. There will be an array of UK healthcare professionals, and other relevant decision makers who have a specific interest in vaccine intervention in the patient pathway.

Please share the flyer for the event available here with your colleagues.

If you have any queries, or would like to enquire about sponsorship of this event, please contact:


Seqirus has sponsored this conference but has had no input into the arrangements or the content except the session on “Improving Influenza Vaccine Uptake” which has specifically been sponsored and arranged by Seqirus.

To view the recordings from the online UK Clinical Vaccine Network Conference held in 2020 please click here Clinical Vaccines Network Virtual Conference 2020

Professor Merryn Voysey

Merryn Voysey is Associate Professor of Statistics in Vaccinology at the Oxford Vaccine Group. She has extensive experience in vaccines research including clinical trials and observational studies, and is the lead methodologist for the Oxford-AstraZeneca vaccine trials. Her current research interests include maternal antibody interference, vaccine correlates of protection, and the seroepidemiology of bacterial infections
She is the Principal Investigator on an individual participant data meta-analyses of serological data from vaccine clinical trials funded through the NIHR HTA and, and a multi-country study of maternal measles seroprevalence in infants funded by the Bill and Melinda Gates Foundation.